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The lipocalin mouse 24p3 has been impli-
cated in diverse physiological processes,
including apoptosis due to interleukin-3
(IL-3) deprivation and iron transport. Here
we report cloning of the 24p3 cell-surface
receptor (24p3R). Ectopic 24p3R expres-
sion confers on cells the ability to undergo
either iron uptake or apoptosis, dependent
upon the iron content of the ligand: Iron-
loaded 24p3 increases intracellular iron
concentration without promoting apopto-
sis; iron-lacking 24p3 decreases intracellu-
lar iron levels, which induces expression of
the proapoptotic protein Bim, resulting in
apoptosis. Intracellular iron delivery blocks
Bim induction and suppresses apoptosis
due to 24p3 addition or IL-3 deprivation.
We find, unexpectedly, that the BCR-ABL
oncoprotein activates expression of 24p3
and represses 24p3R expression, render-
ing BCR-ABL+ cells refractory to secreted
24p3. By inhibiting BCR-ABL, imatinib in-
duces24p3Rexpressionand,consequently,
apoptosis. Our results reveal an unantici-
pated role for intracellular iron regulation in
anapoptotic pathway relevant toBCR-ABL-
induced myeloproliferative disease and its
treatment.
INTRODUCTION
Apoptosis is a physiological form of cell death that has been
broadly implicated in disparate biological processes, includ-
ing normal development, tissue homeostasis, and defense
against pathogens (reviewed in Datta et al., 1999; Vaux andCellKorsmeyer, 1999). There is substantial evidence that
certain apoptotic programs are transcriptionally regulated.
For example, the p53 tumor suppressor pathway induces
apoptosis, at least in part, by transcriptional activation of p53-
dependent genes (Polyak et al., 1997). Other transcription-
dependent apoptotic programs include glucocorticoid-
induced killing of thymocytes (Cohen and Duke, 1984; Galili
et al., 1982) and cell death induced by signaling through
the T cell receptor (Lenardo et al., 1999).
In some cells, apoptosis is induced by deprivation of tro-
phic factors. For example,many hematopoietic cells undergo
apoptosis when deprived of a specific cytokine such as inter-
leukin 3 (IL-3). Significantly, apoptosis induced by IL-3 with-
drawal can be blocked by the transcription inhibitor actino-
mycin D or the translation inhibitor cycloheximide, implying
a requirement for gene expression (Ishida et al., 1992).
Using DNAmicroarrays to analyze IL-3-dependent murine
pro-B lymphocytic FL5.12 cells, we found that the gene un-
dergoing maximal transcriptional induction following cyto-
kine withdrawal is the lipocalin 24p3 (also called lipocalin 2)
(Devireddy et al., 2001). Lipocalins are a family of secreted
proteins that can bind small molecular weight ligands (Aker-
strom et al., 2000; Flower, 1996) and have diverse molecular
recognition properties and functions including retinol trans-
port, cryptic coloration, olfaction, pheromone transport, and
prostaglandin synthesis (reviewed in Akerstrom et al., 2000;
Flower, 1996).
We have previously shown that conditioned medium (CM)
from IL-3-deprived FL5.12 cells contains 24p3 and induces
apoptosis of naı¨ve FL5.12 cells even when IL-3 is present
(Devireddy et al., 2001). Furthermore, CM from IL-3-deprived
FL5.12 cells or COS-7 cells expressing 24p3, as well as
purified 24p3, induces apoptosis in a variety of hematopoietic
cells. Based upon these results, we have proposed that IL-3
deprivation activates 24p3 transcription, leading to synthesis
and secretion of 24p3, which induces apoptosis through an
autocrine/paracrine pathway.
Recently, several studies have found that 24p3 can bind
iron and deliver it to cells (Goetz et al., 2002; Yang et al.,
2002, 2003). 24p3 does not have an intrinsic ability to in-
teract with iron, but iron is instead bound through a 24p3-
associated small molecular weight siderophore (Goetz et al.,123, 1293–1305, December 29, 2005 ª2005 Elsevier Inc. 1293
Figure 1. Sequence and Expression Analysis of 24p3R
(A) Full-length sequence of the murine 24p3R. Highlighted sequences represent putative transmembrane domains. The asterisk denotes the initiating me-
thionine of the short form of 24p3R, 24p3R-S. Arrowheads indicate the N-terminal boundary of the isolated 24p3-interacting clones.
(B) Characterization of the a-24p3R antibody. Immunoblot analysis in MDCK cells using an a-24p3R antibody incubated with excess immunogenic peptide
or an unrelated peptide. The asterisk indicates proteolytic products of 24p3R.
(C and D) Immunoblot analysis on a panel of murine tissues (C) and cell lines (D). A higher molecular weight form of 24p3R is indicated by the arrowhead.
(E) RT-PCR analysis monitoring expression of 24p3R-L, 24p3R-S, 24p3, and, as a control, GAPDH in whole embryos during different stages of mouse
development.2002; Yang et al., 2002). Following cellular uptake of 24p3
by endocytosis, the bound iron is released, resulting in an
increased intracellular iron concentration (Yang et al., 2002).
The observation that 24p3 is a secreted protein that is in-
ternalized through an endocytotic mechanism suggests the
existence of a 24p3 cell-surface receptor. Here we report the
isolation of a 24p3 cell-surface receptor and show how a sin-
gle receptor can mediate diverse physiological processes
dependent upon the state of the ligand and independent of
cell type.
RESULTS
Isolation of a 24p3 Cell-Surface Receptor
To isolate a cell-surface receptor for 24p3 (24p3R), we per-
formed expression cloning using a cDNA library prepared
frommurine FL5.12 cells, which are highly sensitive to 24p3-
mediated apoptosis (Devireddy et al., 2001). The cDNA1294 Cell 123, 1293–1305, December 29, 2005 ª2005 Elsevier Inlibrary was transfected into COS-7 cells and, after three
rounds of panning, two clones were identified that conferred
maximal 24p3 binding activity. DNA sequence analysis re-
vealed that the two clones contained an overlapping DNA
sequence, whichmatched a database entry proposed to en-
code amurine protein namedbrain type organic cation trans-
porter (BOCT) (GenBank accession number NM_021551).
Database searches also revealed the presence of a highly
conserved human homolog (NM_016609). The full-length
murine cDNA contained a single open reading frame of 520
amino acids that is predicted to contain 12 transmembrane
helices (Figure 1A).
To determine the expression pattern of 24p3R, we raised
and affinity-purified a polyclonal antibody using as an immu-
nogen a C-terminal 24p3R peptide. The a-24p3R antibody
detected a 60 kDa polypeptide in MDCK kidney epithelial
cells (Figure 1B) as well as other cell lines and murine tissues
(see below), consistent with the predicted size of 24p3R.
Figure 1B shows that detection of the 60 kDa polypeptidec.
Figure 2. HeLa Cells Stably Expressing 24p3R Bind and Internalize 24p3
(A) Ligand-cell binding experiments. HeLa cells stably expressing 24p3R-S (HeLa/24p3R-S), 24p3R-L (HeLa/24p3R-L), or the empty expression vector
(HeLa/X7) were incubated with 32P-labeled 24p3 as previously described (Devireddy et al., 2001) together with excess unlabeled 24p3 or transferrin. Error
bars represent standard deviation.
(B) 24p3 internalization assay. Cells were incubated with 32P-labeled 24p3 and at various time-points protease treated, collected, washed, and counted.
(C) 24p3 localization. Cells were incubated with 24p3-Alexa568, fixed, and analyzed by confocal microscopy.was blocked by incubation of the antiserum with the peptide
immunogen but not an unrelated peptide.
Immunoblot analysis on a panel of murine tissues revealed
that 24p3R was widely expressed (Figure 1C). Several tis-
sues, such as spleen and testis, had a smaller,30 kDa form
of 24p3R. RT-PCR analysis and EST database searches
(data not shown) indicated that this shorter form represented
an alternatively spliced variant lacking the N-terminal 154
amino acids (Figure 1A). We will refer to these forms as
24p3R-long (24p3R-L) and 24p3R-short (24p3R-S). Immu-
noblot analysis of a panel of cell lines revealed that 24p3R-L
was expressed in MDCK, FL5.12, and 32D (IL-3-dependent
murinemyeloid) cells but not inHeLa cells (Figure 1D). FL5.12
and 32D cells also expressed a higher molecular weight form
of 24p3R. Significantly, 24p3R was not expressed in human
Jurkat or murine D1-F4 cells, two hematopoietic cell lines
that are atypically resistant to 24p3-mediated apoptosis
(Devireddy et al., 2001). RT-PCR analysis during different
mouse embryonic stages revealed that 24p3R-L was ex-
pressed as early as day 7 and persisted throughout develop-
ment (Figure 1E).
We next asked whether ectopically expressed 24p3R
was able to bind and mediate internalization of 24p3. AsCelldescribed above, 24p3R is not detectably expressed in HeLa
cells. To perform functional experiments, we derived HeLa
cell lines stably expressing 24p3R-S and 24p3R-L (HeLa/
24p3R-S and HeLa/24p3R-L) and, as a control, the empty
expression vector (HeLa/X7). The ligand-cell binding experi-
ments of Figure 2A show that 32P-labeled 24p3 bound to
HeLa/24p3R-S and HeLa/24p3R-L cells but not to HeLa/X7
cells. Binding of 32P-labeled 24p3 to HeLa/24p3R-S and
HeLa/24p3R-L cells was blocked by addition of excess
unlabeled 24p3 but not the unrelated protein, transferrin.
Scatchard analysis indicates that 24p3R-S has a slightly
higher affinity than 24p3R-L for 24p3 (data not shown).
Following addition to cells, 24p3 (Yang et al., 2002) and
other lipocalins (Wojnar et al., 2003; Yang et al., 2002) are in-
ternalized by endocytosis. Figure 2B shows that 32P-labeled
24p3 was internalized following addition to HeLa/24p3R-S
andHeLa/24p3R-Lbut not toHeLa/X7cells. Likewise, Figure
2C shows that Alexa568-derivatized 24p3 (24p3-Alexa568)
accumulated at the surface and within HeLa/24p3R-S and
HeLa/24p3R-L but not within HeLa/X7 cells. Collectively,
the results of Figure 2 show that ectopic expression of
24p3R confers onHeLa cells the ability to bind and internalize
24p3.123, 1293–1305, December 29, 2005 ª2005 Elsevier Inc. 1295
Figure 3. Depletion of Intracellular Iron by Apo-24p3 in Cells Expressing 24p3R
(A) Analysis of intracellular iron concentration by monitoring expression of ferritin protein levels by immunoblotting in untreated cells (control) or cells treated
with recombinant iron-lacking 24p3 (apo-24p3), recombinant iron-loaded 24p3 (holo-24p3), CM from IL-3-deprived FL5.12 cells [FL5.12(-)CM], desferriox-
amine (DFO), or holo-transferrin (holo-Tf). Tubulin levels were also monitored as a control.
(B) Colorimetric analysis of intracellular iron concentration. Error bars represent standard deviation.
(C) Determination of intracellular iron concentration by fluorescence calcein assay.
(D) Determination of intracellular iron concentration by immunoblot analysis of HIF-1a expression (left) and NIP3 transcription by luciferase reporter gene
activity (right).24p3-Mediated Iron Uptake in Cells Expressing 24p3R
We next asked whether ectopic 24p3R expression would
confer on HeLa cells the ability to uptake iron in a ligand-
dependent fashion. In these experiments as well as those
described below, we compared three preparations of 24p3:
recombinant iron-loaded 24p3 (holo-24p3), recombinant
iron-lacking 24p3 (apo-24p3), and CM from IL-3-deprived
FL5.12 cells, which contains 24p3 [FL5.12(-)CM] (Devireddy1296 Cell 123, 1293–1305, December 29, 2005 ª2005 Elsevier Inet al., 2001). The three preparations of 24p3 were added
to HeLa/24p3R-S, HeLa/24p3R-L, or HeLa/X7 cells, in par-
allel with iron-containing transferrin (holo-Tf) and the mem-
brane-permeable iron chelator desferrioxamine (DFO) as
controls.
To monitor intracellular iron concentration, we analyzed
by immunoblotting the level of ferritin protein; translation of
ferritin mRNA is iron regulated (Rouault and Klausner, 1997).c.
The results of Figure 3A show, as expected, that holo-Tf in-
creased intracellular iron concentration in all three HeLa cell
lines, as evidenced by enhanced levels of ferritin protein. Sig-
nificantly, holo-24p3 also increased intracellular iron concen-
tration inHeLa/24p3R-SandHeLa/24p3R-Lbut not inHeLa/
X7 cells. By contrast, addition of apo-24p3, FL5.12(-)CM, or
DFO did not increase intracellular iron in any of the three cell
lines.
To confirm these results, we used a colorimetric assay to
measure intracellular iron concentration (Leardi et al., 1998).
Figure 3B shows that addition of holo-24p3 increased intra-
cellular iron in HeLa/24p3R-S and HeLa/24p3R-L cells but
not in HeLa/X7 cells. Unexpectedly, addition of apo-24p3
and FL5.12(-)CM substantially reduced intracellular iron con-
centration in HeLa/24p3R-S and HeLa/24p3R-L cells. Col-
lectively, the results of Figures 3A and 3B indicate that
24p3R can mediate intracellular iron delivery by holo-24p3.
Depletion of Intracellular Iron by Apo-24p3
in Cells Expressing 24p3R
The results of Figure 3B raised the possibility that apo-24p3
acted as an iron chelator to lower intracellular iron concentra-
tion. To confirm this idea, we performed a second assay that
measured intracellular iron levels using the iron sensor dye,
calcein. Calcein is a fluorescent, cell-permeable dye whose
emission is quenched by iron binding (Epsztejn et al.,
1997). The results of Figure 3C show that in calcein-loaded
HeLa/24p3R-L cells, there was an increase in fluorescence
emission following addition of apo-24p3 and FL5.12(-)CM,
indicating a decrease in intracellular free iron. We also ana-
lyzed the expression of two genes, HIF-1a and NIP3, which
are upregulated following a decrease in intracellular iron con-
centration (Chong et al., 2002). The results of Figure 3D show
that apo-24p3 and FL5.12(-)CM increased HIF-1a protein
levels (left) and NIP3 transcription (right) in HeLa/24p3R-S
and HeLa/24p3R-L but not in HeLa/X7 cells. As expected,
DFO induced expression of HIF-1a and NIP3 in all three
cell lines.
We next investigated the pathway by which apo-24p3
lowers intracellular iron levels. HeLa/X7 and HeLa/24p3R-L
cells were preincubated with 55Fe, recultured in fresh me-
dium lacking 55Fe, and then treated with apo-24p3. We first
confirmed that 24p3 bound intracellular 55Fe by immunopre-
cipitation of cell lysates. The results of Figure 4A show that
there was substantial association of 55Fe with 24p3 in HeLa/
24p3R-L but not in HeLa/X7 cells. We next asked whether
24p3 simply sequestered intracellular iron or transferred it
to the extracellular medium. HeLa/X7 and HeLa/24p3R-L
cells were preincubated with 55Fe, recultured in fresh me-
dium lacking 55Fe, treated with apo-24p3 or, as a control,
DFO, and the accumulation of 55Fe in the medium was de-
termined by liquid scintillation counting. Figure 4B shows
that addition of apo-24p3 or DFO to HeLa/24p3R-L cells
led to a time-dependent accumulation of 55Fe in the me-
dium. By contrast, in HeLa/X7 cells only DFO affected the
distribution of 55Fe. To verify that 55Fe was transferred out-
side the cell by 24p3, HeLa/X7 and HeLa/24p3R-L cells
were treated as described above and, after 24 hr, the cellsCellwere washed to remove any residual extracellular apo-
24p3 and newly secreted 55Fe-associated 24p3 was ana-
lyzed by immunoprecipitation. Figure 4C shows that 55Fe-
associated 24p3 accumulated in the extracellular medium.
Collectively, these results indicate that in cells expressing
24p3R, apo-24p3 is internalized, binds to intracellular 55Fe,
and transfers it to the extracellular medium, resulting in de-
creased intracellular iron levels.
We considered the possibility that 24p3 exited the cell
through an endosome recycling pathway, as occurs for sev-
eral other endocytosed receptor-ligand complexes (Maxfield
and McGraw, 2004). As a first test of this idea, we asked
whether intracellular 24p3 was present in recycling endo-
somes as evidenced by colocalization with Rab11, a well-
established recycling endosome marker (Maxfield and
McGraw, 2004). HeLa/24p3R-L cells were transfected with
a plasmid expressing a GFP-Rab11 fusion-protein, followed
by addition of 24p3-Alexa568 and visualization by immuno-
fluorescence microscopy. The results of Figure 4D (upper
panel) indicate that much of 24p3-Alexa568 colocalized
with GFP-Rab11, indicating that a portion of intracellular
24p3 is associated with recycling endosomes.
To confirm these results, we also analyzed 24p3-Alexa568
localization, following introduction of two proteins that, when
overexpressed, alter the intracellular distribution and inhibit
the function of recycling endosomes: Rab11-S29F, a domi-
nant-negative Rab11 mutant (Pasqualato et al., 2004), and
Rififylin, a component of recycling endosomes (Coumailleau
et al., 2004). Figure 4D (middle panel) shows that relative to
wild-type GFP-Rab11, GFP-Rab11-S29F assumed a more
condensed, perinuclear distribution, consistentwith previous
results (Pasqualato et al., 2004). Significantly, GFP-Rab11-
S29F altered the distribution of and colocalized with 24p3-
Alexa568. As expected from previous studies (Coumailleau
et al., 2004), expression of GFP-Rififylin also resulted in peri-
nuclear accumulation of the recycling endosome compart-
ment (Figure 4D, lower panel). Likewise, GFP-Rififylin altered
the distribution of and colocalized with 24p3-Alexa568.
We next sought to verify that 24p3-mediated iron export
required recycling endosome function. HeLa/X7 and HeLa/
24p3R-L cells were transfected with a plasmid expressing
GFP-Rab11-S29F or GFP-Rififylin. The cells were then pre-
incubated with 55Fe, and the ability of DFO or apo-24p3 to
transfer intracellular iron to the extracellular medium was an-
alyzed. The results of Figure 4E show that addition of DFO to
either HeLa/X7 or HeLa/24p3R-L cells resulted in the accu-
mulation of 55Fe in the extracellular medium, which was un-
affected by Rab11-S29F or Rififylin. By contrast, apo-24p3
promoted the accumulation of 55Fe in the extracellular me-
dium only in HeLa/24p3R-L cells; this accumulation was in-
hibited by both Rab11-S29F and Rififylin. Thus, recycling en-
dosome function is required for 24p3-mediated iron export.
As mentioned above, 24p3 binds iron through an associ-
ated siderophore (Yang et al., 2002). We therefore sought
to identify the step in the 24p3-mediated intracellular iron-
depletion pathway where 24p3 becomes siderophore asso-
ciated. We first asked whether the 24p3 present in CM from
IL-3-deprived FL5.12 cells was able to bind iron. 55Fe was123, 1293–1305, December 29, 2005 ª2005 Elsevier Inc. 1297
Figure 4. The 24p3-Mediated Intracellular Iron Depletion Pathway
(A) Analysis of 24p3 association with intracellular 55Fe. Cells were preincubated with 55Fe, recultured in fresh medium lacking 55Fe, and then treated with
apo-24p3. Cell lysates were immunoprecipitated with an anti-24p3 antibody (a-24p3) or, as a negative control, rabbit serum 0, 6, or 24 hr following apo-
24p3 treatment. Error bars represent standard deviation.
(B) Analysis of 55Fe transfer to the extracellular medium. Cells were treated as described in (A), and the accumulation of 55Fe in the medium was analyzed
after addition of apo-24p3 or DFO.
(C) Analysis of 24p3 association with extracellular 55Fe. Cells were treated as described in (A), washed to remove extracellular apo-24p3, and the extracel-
lular medium was immunoprecipitated with a-24p3 or rabbit serum 0, 6, or 24 hr later.
(D) Localization of intracellular 24p3 to recycling endosomes. HeLa/24p3R-L cells were electroporated with GFP-Rab11, GFP-Rab11-S29F, or GFP-Rififylin
expression plasmids. After 6 hr, cells were incubated with 24p3-Alexa568 for 40 min in medium containing 1% serum, and after washing and fixation they
were examined by fluorescence microscopy.
(E) Dependence of 24p3-mediated iron export on recycling endosome function. HeLa/X7 and HeLa/24p3R-L cells were transfected with a GFP, GFP-
Rab11-S29F, or GFP-Rififylin expression plasmid, loaded with 55Fe, and following a 2 hr incubation with 24p3 or DFO, transfer of iron to the extracellular
medium was measured.
(F) 24p3 associates with the siderophore intracellularly. 55Fe was added to FL5.12(-)CM and FL5.12(+)CM or to various control media in combination with
apo-24p3, and association with 24p3 in the media was determined by immunoprecipitation.
(G) Association of 24p3with the siderophore is dependent upon 24p3R. (Top) Immunoblot analysis for 24p3 in the CM. (Bottom) 55Fewas added to HeLa/X7
and HeLa/24p3R-L cells transfected with a control, 24p3 and/or 24p3R expression plasmid, and association with 24p3 in the CM was determined by
immunoprecipitation.
(H) Schematic summary of the 24p3-mediated intracellular iron depletion pathway.added to CM from FL5.12 cells cultured in the absence or
presence of IL-3 [FL5.12(-)CM or FL5.12(+)CM, respectively]
or various control media, and association with 24p3 was
determined by immunoprecipitation. The results of Figure 4F
indicate that the 24p3 in FL5.12(-)CM was siderophore
associated, as evidenced by its ability to bind 55Fe. How-1298 Cell 123, 1293–1305, December 29, 2005 ª2005 Elsevier Inever, when recombinant apo-24p3 was added to fresh, un-
conditioned medium or to FL5.12(+)CM, binding of 55Fe was
not detected, indicating that the siderophore is not present
in the extracellular medium. Collectively, these results indi-
cate that apo-24p3 associates with the siderophore intra-
cellularly.c.
Figure 5. 24p3-Mediated Apoptosis in Cells Expressing 24p3R
(A) Apoptosis was quantitated by annexin V-FITC staining (top) or immunoblot analysis of PARP cleavage (bottom). Apoptosis and PARP cleavage were
analyzed 72 and 24 hr after treatment, respectively. Error bars represent standard deviation.
(B) Apoptosis was monitored in MDCK cells by annexin V-FITC staining 48 hr after treatment.
(C) Holo-Tf was analyzed for its ability to block apoptosis 48 hr after addition of apo-24p3, FL5.12(-)CM, or DFO (left) or 24 hr after addition of staurosporine
or etoposide (right).The finding that 24p3 associates with the siderophore in-
tracellularly raised the possibility that this event was pro-
moted by internalization of 24p3 through 24p3R. To test
this idea, HeLa/X7 and HeLa/24p3R-L cells were transiently
transfected with a plasmid expressing 24p3, and after 48 hr
the 24p3 in the CM was tested for its ability to bind
55Fe. Figure 4G shows that CM from HeLa/X7 and HeLa/
24p3R-L cells contained comparable amounts of 24p3 (top).
However, only the 24p3 in CM from HeLa/24p3R-L cells
was able to bind 55Fe (bottom), indicating that the 24p3 in
CM from HeLa/24p3R-L cells but not HeLa/X7 cells was
siderophore associated. Coexpression of 24p3R in HeLa/
X7 cells substantially increased the ability of 24p3 to bind
55Fe. These results suggest that following synthesis, apo-
24p3 is initially secreted in a siderophore-free state and as-
sociates with the siderophore intracellularly following endo-
cytosis. Based upon the results of Figure 4 and the generalCellparadigm of other endocytosed ligand-receptor complexes
(Maxfield and McGraw, 2004), we propose a pathway for
24p3-mediated iron depletion that is summarized in
Figure 4H.
24p3-Mediated Apoptosis in Cells Expressing 24p3R
We next examined the ability of 24p3R to mediate 24p3-
dependent apoptosis. The different preparations of 24p3
were added to the three HeLa cell lines, and apoptosis was
analyzed by annexin V-FITC staining. Figure 5A shows that
apo-24p3 and FL5.12(-)CM induced apoptosis in HeLa/
24p3R-S and HeLa/24p3R-L cells but not in HeLa/X7 cells.
We confirmed that cell deathwas due to apoptosis by analyz-
ing proteolytic cleavage of poly(ADP-ribose) polymerase
(PARP) (Figure 5A, bottom). By contrast, addition of holo-
24p3 failed to induce apoptosis in HeLa/24p3R-S andHeLa/
24p3R-L cells. As expected from previous studies (reviewed123, 1293–1305, December 29, 2005 ª2005 Elsevier Inc. 1299
Figure 6. Apoptosis due to IL-3 Deprivation is Regulated by Intracellular Iron Levels and Involves Induction of Bim
(A) Determination of intracellular iron concentration by fluorescence calcein assay.
(B) Apoptosis assays. Holo-Tf and FeCl3 were analyzed for their ability to block apoptosis 1 hr after IL-3 deprivation or after addition of doxorubicin or cis-
platin. Error bars represent standard deviation.
(C) Immunoblot analysis of Bim levels.
(D) Suppression of apoptosis by a Bim shRNA.
(E) Immunoblot analysis of Bim levels.in Le and Richardson, 2002), the iron chelator DFO induced
apoptosis in all three cell lines. Identical results were obtained
inMDCK kidney cells (Figure 5B), which contain high levels of
24p3R (see Figure 1D) and have been previously used to
study 24p3-mediated iron delivery (Yang et al., 2002).
The above results indicate that apo-24p3andFL5.12(-)CM
decrease intracellular iron levels and induce apoptosis in
cells expressing 24p3R. It is well established that iron chela-
tors can induce apoptosis (Le and Richardson, 2002). We
reasoned that if the basis of 24p3-mediated apoptosis was
in fact decreased intracellular iron concentration, then cell
death should be prevented by delivery of iron through an al-
ternative pathway. To test this prediction, we analyzed the
ability of holo-Tf to block 24p3-mediated apoptosis. The
results indicate that holo-Tf suppressed apoptosis induced
by either apo-24p3, FL5.12(-)CM, or DFO (Figure 5C, left).
By contrast, holo-Tf had no effect on apoptosis induced by1300 Cell 123, 1293–1305, December 29, 2005 ª2005 Elsevier Instaurosporine, a protein kinase C inhibitor, or etoposide,
a DNA-damaging agent (Figure 5C, right).
Regulation of Apoptosis due to IL-3 Deprivation
through Intracellular Iron Levels
Following cytokine deprivation, IL-3-dependent cell lines,
such as FL5.12 cells, synthesize and secrete 24p3 (Devir-
eddy et al., 2001). The similar behavior of recombinant
apo-24p3 and FL5.12(-)CM in the experiments described
in Figures 3 and 5 suggested that the majority of 24p3 in
the FL5.12(-)CM was in the apo form. We therefore pre-
dicted that intracellular iron levels in FL5.12 cells would de-
crease following IL-3 deprivation. To test this prediction,
we measured intracellular iron levels in FL5.12 cells in the
presence or absence of IL-3 using the fluorescence calcein
assay. The results of Figure 6A show that in calcein-loaded
FL5.12 cells there was a large increase in fluorescencec.
emission following withdrawal of IL-3 or addition of DFO,
apo-24p3, or FL5.12(-)CM. Thus, in FL5.12 cells, IL-3 dep-
rivation leads to reduced intracellular iron levels. To confirm
that reduced intracellular iron levels contributed to apopto-
sis, we analyzed the ability of holo-Tf or ferric chloride
(FeCl3) to block apoptosis following IL-3 deprivation. The re-
sults of Figure 6B show that addition of either holo-Tf or
FeCl3 significantly suppressed apoptosis in IL-3-deprived
FL5.12 cells. By contrast, holo-Tf or FeCl3 had no effect on
FL5.12 cell apoptosis induced by the DNA-damaging agents
doxorubicin and cisplatin. Identical results were obtained in
32D cells, another IL-3-dependent cell line.
Induction of the BH3-Only Protein Bim by IL-3
Deprivation, Apo-24p3, and Iron Chelators
We next sought to understand how a reduction in intracellu-
lar iron levels functioned through the core apoptotic machin-
ery to promote cell death. Previous studies have shown that
cytokine deprivation of IL-3-dependent cell lines results in
the induction (Kuribara et al., 2004; Shinjyo et al., 2001)
and posttranslational activation (Harada et al., 2004) of Bim,
a BH3-only proapoptotic member of the Bcl-2 family (re-
viewed in Strasser et al., 2000). Ectopic expression of Bim
induces apoptosis (Shinjyo et al., 2001) and, conversely,
small interfering RNA (siRNA) mediated Bim knockdown
suppresses apoptosis following IL-3 deprivation (Harada
et al., 2004).
These considerations prompted us to investigate the role
of Bim in 24p3- and iron chelator-mediated apoptosis. The
immunoblot of Figure 6C shows, consistent with previous
studies (Kuribara et al., 2004), that IL-3 deprivation of FL5.12
cells resulted in increased levels of a spliced variant of Bim,
called Bim extra-long (BimEL). Significantly, addition of apo-
24p3, FL5.12(-)CM, or DFO resulted in a comparable in-
crease of BimEL levels in FL5.12 and HeLa/24p3R-L cells,
whereas in HeLa/X7 cells BimEL levels were increased only
by DFO.
To confirm that BimEL induction was required for apopto-
sis, we performed RNA interference (RNAi) experiments. We
derived an FL5.12 cell line stably expressing a small hairpin
RNA (shRNA) directed against Bim. Figure 6D shows that
the Bim shRNA substantially reduced apoptosis following
IL-3 deprivation, consistent with previous results (Harada
et al., 2004). Significantly, the Bim shRNA also suppressed
apoptosis resulting from addition of DFO or apo-24p3. Im-
munoblot analysis confirmed that the Bim shRNA efficiently
and selectively reduced BimEL levels. These results indicate
that induction of BimEL is required for efficient apoptosis re-
sulting from IL-3 deprivation or addition of DFO or apo-24p3.
The results of Figures 6A–6C suggested that in IL-3-
deprived cells, Bim expression is induced in response to de-
creased intracellular iron levels. A prediction of this idea is
that intracellular iron delivery would suppress the induction
of Bim expression that normally occurs following IL-3 depri-
vation. Figure 6E shows that in IL-3-deprived FL5.12 cells,
addition of holo-Tf or FeCl3 substantially decreased Bim in-
duction in a manner that correlated with the decreased apo-
ptosis (Figure 6B).Cell 1Reciprocal Misregulation of 24p3 and 24p3R
Expression by BCR-ABL
Certain oncoproteins can render cells growth factor indepen-
dent, which is related to their ability to prevent apoptosis
and promote cell survival. For example, BCR-ABL as well as
someother oncogenic tyrosine kinases can confer resistance
to apoptosis in cytokine-deprived, IL-3-dependent mouse
cell lines (reviewed in Cross and Reiter, 2002; Skorski, 2002).
Because 24p3 is normally transcriptionally activated follow-
ing IL-3 deprivation, BCR-ABL must counteract the expres-
sion or function of the 24p3/24p3R proapoptotic pathway.
To investigate this issue, we first analyzed expression of
24p3 in IL-3-dependent murine 32D and BaF3 cells and in
32D and BaF3 cells expressing BCR-ABL (32D/BCR-ABL
and BaF3/BCR-ABL, respectively) (Nieborowska-Skorska
et al., 1999; Okuda et al., 1996). As expected from our pre-
vious study (Devireddy et al., 2001), in parental 32D and
BaF3 cells, 24p3 was expressed only following IL-3 depriva-
tion (Figure 7A). Unexpectedly, in 32D/BCR-ABL and BaF3/
BCR-ABL cells, 24p3 was constitutively expressed regard-
less of whether IL-3 was present. To confirm that expression
of 24p3 in 32D/BCR-ABL and BaF3/BCR-ABL cells was due
to BCR-ABL, we treated cells with the BCR-ABL inhibitor,
imatinib mesylate (also called STI-571 or Gleevec). Figure 7B
shows that addition of imatinib virtually eliminated 24p3 ex-
pression in 32D/BCR-ABL and BaF3/BCR-ABL cells, verify-
ing the involvement of BCR-ABL.
Theexpressiondataof Figure7Apredict thatCM from32D/
BCR-ABL and BaF3/BCR-ABL cells should contain 24p3
and induce apoptosis in parental 32D and BaF3 cells, which
are sensitive to 24p3-mediated apoptosis (Devireddy et al.,
2001). Consistent with this prediction, Figure 7C shows
that CM from 32D/BCR-ABL and BaF3/BCR-ABL cells in-
duced apoptosis following addition to 32D or BaF3 cells.
The finding that 32D/BCR-ABL and BaF3/BCR-ABL cells
expressed and secreted 24p3 but were viable raised the
possibility that expression or function of 24p3R might be in-
hibited. Figure 7D shows, as expected, that 24p3R was ex-
pressed in the parental 32D and BaF3 cells regardless of
whether IL-3 was present. Significantly, however, 24p3R ex-
pression was substantially reduced in 32D/BCR-ABL and
BaF3/BCR-ABL cells. To confirm that the decreased expres-
sion of 24p3R in 32D/BCR-ABL and BaF3/BCR-ABL cells
was due to BCR-ABL, we analyzed the effect of imatinib ad-
dition. The results of Figure 7E show that following addition of
imatinib to 32D/BCR-ABLandBaF3/BCR-ABL cells cultured
in the presence of IL-3, 24p3R expression increased dramat-
ically to levels approximating those observed in the parental
cells. Imatinib also increased expression of 24p3R and de-
creased expression of 24p3 in 32D/BCR-ABL and BaF3/
BCR-ABL cells cultured in the absence of IL-3 (Figure 7F).
Collectively, the results of the expression analyses sug-
gested that 32D/BCR-ABL and BaF3/BCR-ABL cells were
viable because 24p3R expression was downregulated. A
prediction of this idea is that ectopic expression of 24p3R
in 32D/BCR-ABL and BaF3/BCR-ABL cells would induce
cell death. Figure 7G shows that transfection of a 24p3R-
expression plasmid induced apoptosis in 32D/BCR-ABL and23, 1293–1305, December 29, 2005 ª2005 Elsevier Inc. 1301
Figure 7. Reciprocal Misregulation of 24p3 and 24p3R Expression by BCR-ABL
(A) RT-PCR analysis of 24p3 expression in parental 32D or BaF3 cells and in 32D and BaF3 cells expressing BCR-ABL (32D/BCR-ABL and BaF3/BCR-ABL,
respectively) in the presence or absence of IL-3.
(B) RT-PCR analysis of 24p3 expression in 32D/BCR-ABL and BaF3/BCR-ABL cells 8 hr following treatment with 10 mM imatinib (STI).
(C) Apoptosis assays. Apoptosis was analyzed in 32D and BaF3 cells cultured in FL5.12(-)CM, FL5.12(+)CM, 32D/BCR-ABL(+)CM, or BaF3/BCR-
ABL(+)CM for 72 hr. Error bars represent standard deviation.
(D) RT-PCR analysis of 24p3R expression.
(E and F) RT-PCR analysis following imatinib treatment of 32D/BCR-ABL and BaF3/BCR-ABL cells in the presence or absence of IL-3.
(G) Apoptosis assays. Cells cultured in the presence of IL-3 were transfected with a plasmid expressing 24p3R, and apoptosis was analyzed 48 hr later.
(H) Suppression of imatinib-mediated apoptosis by a 24p3 siRNA. The 24p3 siRNA was directed against the sequence 50-AAGGCAGCTTTACGATGTA-30;
the control siRNA (50-CTTACGCTGAGTACTTCGA-30) was directed against luciferase.
(I) Apoptosis assays (top) and analysis of Bim levels (bottom) in cells treated with imatinib, holo-Tf, and/or FeCl3.
(J) RT-PCR analysis of 24p3 and 24p3R expression in primary bone marrow cells transduced with a retrovirus expressing either BCR-ABL or, as a control,
GFP.
(K) RT-PCR analysis of 24p3 and 24p3R expression in peripheral blood mononuclear cells from CML blast crisis patients (CML) or pooled peripheral blood
mononuclear cells from normal (NL) volunteers.BaF3/BCR-ABL cells but not in the parental 32D or BaF3
cells.
Imatinib induces apoptosis in BCR-ABL+ cells (Deininger
et al., 2005). Our finding that in BCR-ABL+ cells imatinib in-
creases 24p3R expression, thus restoring a functional 24p3/
24p3R pathway, suggested that this may be the basis of
imatinib-mediated apoptosis. To test this idea we first per-
formed an RNAi experiment to determine whether imatinib-
mediated apoptosis was dependent upon 24p3. Figure 7H
shows that an siRNA directed against 24p3 efficiently re-1302 Cell 123, 1293–1305, December 29, 2005 ª2005 Elsevier Induced 24p3 levels in 32D/BCR-ABL and BaF3/BCR-ABL
cells (bottom) and suppressed killing by imatinib (top). We
also tested whether intracellular iron delivery would prevent
killing of BCR-ABL+ cells by imatinib. Figure 7I shows, as ex-
pected, that imatinib efficiently induced apoptosis in 32D/
BCR-ABL cells, whereas the parental 32D cells were unaf-
fected. Remarkably, holo-Tf or FeCl3 substantially decreased
apoptosis in imatinib-treated 32D/BCR-ABL cells. Consis-
tent with previous results (Kuribara et al., 2004), imatinib
treatment of 32D/BCR-ABL cells induced Bim expressionc.
(Figure 7I, bottom). Significantly, addition of holo-Tf or FeCl3
suppressed induction of Bim expression in a manner that
correlated with the decreased apoptosis.
We next asked whether BCR-ABL would also misregulate
24p3 and 24p3R expression in primary cells. Primary mouse
bone marrow cells were transduced with a retrovirus ex-
pressing BCR-ABL or, as a control, green fluorescent pro-
tein (GFP). The results of Figure 7J show that in BCR-ABL-
expressing primary bone marrow cells, 24p3 expression
was increased and 24p3R expression was reduced, analo-
gous to the results obtained in the BCR-ABL+ transformed
cell lines.
Finally, we performed comparable expression analysis in
leukemic blasts isolated from chronicmyelogenous leukemia
(CML) blast crisis patients. The human homolog of 24p3 is
neutrophil gelatinase-associated lipocalin (Ngal) (Bundgaard
et al., 1994), andwewill refer to the humanhomologof 24p3R
asNgalR. Figure 7K shows that three independent CMLblast
isolates expressed high levels of NGAL and virtually unde-
tectable levels of NGALR, analogous to the results obtained
in BCR-ABL+ mouse cells. By contrast, pooled peripheral
blood lymphocytes from normal donors expressed high lev-
els of NGALR and very low levels of NGAL.
DISCUSSION
On the basis of the results in this report and recent studies
(Goetz et al., 2002; Yang et al., 2002, 2003), we propose
the following model for the distinct activities elicited by
24p3. We have found that the iron status of 24p3 is the crit-
ical determinant of its activity. Holo-24p3 binds to 24p3R, is
internalized, and releases its bound iron, thereby increasing
intracellular iron concentration. By contrast, apo-24p3 binds
to 24p3R, is internalized, and following association with an
intracellular siderophore, chelates iron and transfers it to
the extracellular medium, thereby reducing intracellular iron
concentration and resulting in apoptosis (Figure 4H).
24p3-Mediated Apoptosis and Implications for
BCR-ABL-Mediated Myeloproliferative Disease
Decreasing intracellular iron levels is known to induce apo-
ptosis and, in fact, iron chelators are currently under investi-
gation as anticancer agents (Le and Richardson, 2002). To
our knowledge, however, 24p3/24p3R is the first example
of a biological pathway in which apoptosis is regulated
through intracellular iron concentration. Our results reveal
an unanticipated role for regulation of intracellular iron levels
in apoptosis induced by IL-3 deprivation.
We have found that an important aspect of this apoptotic
mechanism is induction of the proapoptotic Bim protein in
response to decreased intracellular iron. Ectopic expression
of Bim can induce apoptosis (Shinjyo et al., 2001), and
Bim is required for apoptosis resulting from IL-3 deprivation
(Harada et al., 2004; Figure 6D) or addition of apo-24p3 or
DFO (Figure 6D). We have found that agents that reduce
intracellular iron levels increase BimEL levels. Most impor-
tantly, intracellular iron delivery blocks induction of Bim ex-Cellpression and apoptosis following IL-3 deprivation, addition
of 24p3, or addition of DFO.
Unexpectedly, we found that in mouse cell lines, BCR-
ABL profoundly misregulates expression of both 24p3 and
24p3R. 24p3 was dramatically upregulated in BCR-ABL+
mouse cell lines, primary mouse cells, and leukemic blasts
isolated from CML patients. Consistent with our results, a
recent study reported that 24p3 is upregulated in BCR-
ABL-transformed mouse cell lines (Lin et al., 2005), and
expression profiling identified NGAL as one of the genes up-
regulated in CML leukemic cells (Kaneta et al., 2003). Signif-
icantly, we also found that 24p3R expression is repressed by
BCR-ABL. Forced expression of 24p3R induces apoptosis
in BCR-ABL-transformed mouse cell lines, indicating that
downregulation of 24p3R is critical for survival in the pres-
ence of the 24p3 secreted in the CM.
Several lines of evidence confirmed that BCR-ABL is re-
sponsible for misregulation of 24p3 and 24p3R expression.
First, misregulation was reversed by addition of imatinib, a
specific BCR-ABL kinase inhibitor. Second, ectopic expres-
sion of BCR-ABL in primary cells resulted in misregulation of
24p3 and 24p3R. Remarkably, killing of BCR-ABL+ cells by
imatinib was blocked by iron delivery, verifying the essential
role of the 24p3/24p3R proapoptotic pathway. Consistent
with our conclusion, BimEL, which we found is involved in
24p3-mediated apoptosis, has been shown to play a critical
role in imatinib-induced cell death (Essafi et al., 2005).
The misregulation of 24p3 and 24p3R expression by
BCR-ABL may be relevant to the severity or progression of
CML.Mice injectedwith BCR-ABL+ cells show atrophy of the
bone marrow, characterized by a severe reduction in normal
hematopoiesis and eventual death (Lin et al., 2001). Based
upon this finding, it has been proposed that BCR-ABL+ cells
secrete one or more factors that interfere with normal hema-
topoiesis and contribute to disease severity (Eaves et al.,
1998). 24p3 has the properties expected of this secreted
factor, and the downregulation of 24p3R expression may ex-
plain the resistance of BCR-ABL+ cancer cells to apoptosis.
EXPERIMENTAL PROCEDURES
Cell Lines
Stable cell lines expressing N-terminal epitope-tagged derivatives of
24p3R-S or 24p3R-L, or the empty expression vector (X7), were derived
by transfection of HeLa cells using FuGene (Roche) and selection with
Blasticidin. FL5.12 cells stably expressing a Bim shRNA directed against
the sequence 50-GCCCAGACATTTGGTCAGTTAT-30 from PSM2 (Open
Biosystems) or, as a control, PSM2 were derived by electroporation and
puromycin selection. Peripheral blood mononuclear cells from CML blast
crisis patients and normal donors were obtained from the human tissue
repository at the University of Massachusetts Medical School, and total
RNA was prepared using TRIzol reagent (Invitrogen).
Expression Cloning of 24p3R
A cDNA library was synthesized from FL5.12 poly(A)+ mRNA using
an oligo-dT primer, and size-selected cDNAs (>1 kb) were directionally
cloned into pCMV-SPORT6 (Gibco-BRL). The library was transfected
into COS-7 cells, and after 36 hr cells were dislodged in PBS containing
0.5 mM EDTA and resuspended in binding buffer (2% BSA in PBS). The
cells were panned on GST-24p3 coated plates (1  107 cells/plate) that123, 1293–1305, December 29, 2005 ª2005 Elsevier Inc. 1303
were prepared as follows. Bacteriological petri plates (Falcon) were lay-
ered with 10 mg/ml anti-mouse IgG (Kirkegaard and Perry Laboratories,
Inc.; KPL) in 50 mM Tris-HCl, pH 9.5, rinsed with 0.15 M NaCl, and
blocked with BSA blocking buffer (KPL). Anti-GST monoclonal antibody
(1 mg/ml) (Santa Cruz Biotechnology) in PBS/2% BSA was added to
each dish and incubated overnight at 4ºC. The plates were washed with
PBS and incubated with 20 mg of purified GST-24p3. Nonadherent cells
were removed by washing with PBS/2% BSA, the adherent cells were
lysed with HIRT buffer, and the plasmid DNA was recovered. After three
rounds of panning, individual plasmids were purified and transfected
into COS-7 cells, which were then screened for their ability to bind
32P-24p3 as described (Devireddy et al., 2001). Inserts from plasmids
that conferred binding to 32P-24p3 were sequenced.
Full-length open reading frames (ORFs) for 24p3R-L and 24p3R-S
were obtained by PCR amplification using IMAGE Clones 5365976 and
4511663, respectively. The ORFs were cloned into a derivative of
pEF6V5-HisB (Invitrogen) containing an N-terminal multi-epitope (FLAG,
S-peptide, and Epitope C) tag (X7).
Antibodies and Immunoblotting
A polyclonal rabbit a-24p3R antibody was raised using a C-terminal
24p3R peptide (CDHVPLLATPNAL) as the immunogen and affinity-
purified on a peptide-coupled Sepharose column. Other antibodies were
obtained as follows: 24p3 (Santa Cruz Biotechnology), ferritin (Sigma),
PARP (BIOMOL), HIF-1a (Santa Cruz Biotechnology), a-tubulin (Sigma),
and Bim (Calbiochem).
24p3 Binding and Internalization Assays
HeLa cells (5  105) constitutively expressing 24p3R were treated with
5  106 cpm 32P-24p3 and analyzed for binding (Devireddy et al., 2001).
For internalization assays, 5  105 cells were treated with 1  106 cpm
32P-24p3 and at various time points washed three times with PBS and in-
cubated for 15 min in a solution of Proteinase K, trypsin, and EDTA to re-
move the extracellular portion of the receptor. Dislodged cells were then
collected, washed, and counted using a Beckman Liquid Scintillation
counter.
Purification and Labeling of Recombinant 24p3
Full-length 24p3 cDNA was cloned into pGEX2TK (Pharmacia) and ex-
pressed in E. coli strains XL1 Blue (Stratagene) or BL21 (Pharmacia).
XL1 Blue constitutively expresses the siderophore enterobactin, and
thus 24p3 derived from this strain is iron loaded (holo-24p3); BL21 lacks
enterobactin, and 24p3 derived from this strain lacks iron (apo-24p3)
(Goetz et al., 2002). Following induction with 1 mM IPTG (Promega), bac-
teria were lysed, and recombinant 24p3 was purified as described
(Bundgaard et al., 1994).
To prepare 32P-labeled 24p3, GST-24p3-Sepharose beads were incu-
bated with 32P-gATP (New England Nuclear) in 1  HMK buffer (20 mM
Tris-HCl pH 7.5, 100 mM NaCl, 12 mM MgCl2) containing 5 U of bovine
heart muscle kinase (Sigma) for 30 min at 4ºC, washed five times with 10
volumes of 1  PBS, and incubated with thrombin to cleave the labeled
24p3. To generate Alexa568-derivatized 24p3, GST-24p3 was immobi-
lized on glutathione agarose (250 ml) in a solution of 500 ml PBS, 0.1M
NaHCO3, and 250 mg Alexa568 (Molecular Probes) for 30 min at room
temperature. After extensive washing to remove the unreacted dye, la-
beled 24p3 was cleaved from the beads using 3 U thrombin (Sigma) in
250 ml PBS for 6 hr at room temperature, and the reaction was stopped
by adding 0.1 mM AEBSF.
Immunofluorescence
For confocal microscopy, 24p3-Alexa568 (10 mg/ml) was added to
2.5  105 chilled cells and incubated for 1 hr at 4ºC followed by 1 hr
at 37ºC. Cells were washed ten times with PBS, fixed in 4% paraformal-
dehyde in PBS, washed in water, and mounted on a glass slide. For
Rab11/Rififylin colocalization experiments, 1 106 cells were transfected
with 2 mg of a plasmid expressing a GFP fusion protein using the Amaxa
electroporator and plated on rat tail collagen-treated coverslips in DMEM+1304 Cell 123, 1293–1305, December 29, 2005 ª2005 Elsevier In10% FCS. Six hours later, cells were incubated in DMEM + 1% FCS and
100 mg/ml of 24p3-Alexa568 for 45 min. Coverslips were washed three
times with complete medium, three times with cold PBS, fixed with 4%
paraformaldehyde in PBS for 30 min, treated with 0.1% sodium borohy-
dride for 20 min, rinsed extensively in PBS, mounted in 90% glycerol,
2%DABCO, 10mMTris pH 7.5, and examined with a Zeiss Axioplan2mi-
croscope.
Intracellular and Extracellular Iron Determination
Colorimetric determination of intracellular iron was measured using ferro-
zine (Sigma) as described (Leardi et al., 1998). For calcein assays, cells
were stained with 0.5 mMCalcein-AM (Molecular Probes) in RPMI (without
phenol red and FBS) for 10 min at room temperature and then washed
three times with RPMI (without phenol red and FBS). Washed cells
were deposited onto glass slides by cytospin, mounted using a mounting
medium (Vector Labs), and observed under a fluorescent microscope. In
most experiments, cells were incubated with 50 mg/ml holo- or apo-24p3,
50 mM FeCl3, 100 mg/ml holo-Tf, or 100 mM DFO (Calbiochem).
For analysis of 24p3 bound intracellular iron, cells were washed once
with ice-cold PBS and lysed with 0.1% Triton-X 100 in PBS for 15 min
on ice. Clarified cell lysate was incubated with 0.2 mg of 24p3 antibody
overnight at 4ºC, followed by incubation with washed Protein A agarose
beads (Santa Cruz Biotechnology) for 4 hr at 4ºC. Beads were collected
by centrifugation and washed three times with PBS and three times with
PBS containing 0.1% Triton-X 100 and then subjected to liquid scintilla-
tion counting. For analysis of 24p3 bound extracellular iron, extracellular
medium was immunoprecipitated and analyzed as described above.
For analysis of total extracellular iron, the counts per minute (cpm) of
the extracellular medium were determined by liquid scintillation counting.
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